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  The X-ray computed tomography （CT） is commonly used to make a diagnosis in hospital. Contrast agents 
are often used to enhance contrast and thus improve diagnostic accuracy. Currently-used clinical contrast 
agents are low molecules. The agents circulate in the bloodstream and are excreted from the kidney or move 
to extravascular tissues through the capillary vessel depending on their concentration gradient. Thus there is a 
situation that the agents nonspecifically enhance the tissues. To image tumor specifically with X-ray CT using 
enhanced permeability and retention effect （EPR effect）, we newly-developed a nano-particulated contrast 
agents made from gold （Au） or silver iodide （AgI）. Au has higher X-ray absorption coefficient than iodine 
which is a normally-used clinical contrast agent. As high blood retention is desirable for effective EPR effect, 
polyethylene glycol （PEG）-supported Au nanoparticles （Au/SiO2-PEG） were prepared. The surface modifica-
tion with PEG is often used to increase the blood retention. We injected the Au/SiO2-PEG nanoparticles into 
the tumor-bearing mice and the distribution of the particles was examined with X-ray CT, showing that the Au/
SiO2-PEG were well-localized to tumor by EPR effect.　However, there was a problem of extracorporeal elimi-
nation for the Au/SiO2-PEG. We developed AgI nanoparticles coated with slilica （AgI/SiO2） as another nano-
particulated contrast agents. The AgI/SiO2 was injected into the rabbit and examined the in vivo biodistribution 
of AgI/SiO2 with X-ray CT and inductively coupled plasma atomic emission spectrometry （ICP-AES）. These 
results showed that the Ag was detected in the bile juice of rabbits with ICP-AES, but it was not found to be 
present in the urine of these animals, suggesting that AgI/SiO2 were excreted via the liver. These concept of 
development of nano-particulated contrast agents would contribute to the advancement of medical science.
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1.　は じ め に
　画像診断は疾患の診断・治療を行う上で非常に







































































































図 1.　Au/SiO2粒子の合成。（a）-（e） Au/SiO2粒子の電子顕微鏡写真。粒子合成反応系の TEOS濃度を変える
ことにより（a : 0.5×10-3M, b : 1×10-3M, c : 3×10-3M, d : 5×10-3M, e : 10×10-3M），ナノ粒子のシリ
カ層のシェル厚を変化させ，約 40～60 nmの範囲で均一な粒子径を保持する様々な Au/SiO2粒子の合
成に成功した（f）。
図 2.　Au/SiO2粒子を用いた腫瘍の X線 CTイメージ














































Seiko 社の SPS 1700HVR を用いて，Inductively 




汁に含まれる Ag量は，15分後から 24 時間後に
図 3.　AgI/SiO2 粒子の合成と排出過程。（a） AgI/SiO2粒子の電子顕微鏡画像。（b） AgI/SiO2粒子の注入前後
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